These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19943806)

  • 21. Plasma homocysteine and markers of bone metabolism in psychogeriatric patients.
    Nilsson K; Gustafson L; Isaksson A; Hultberg B
    Scand J Clin Lab Invest; 2005; 65(8):671-80. PubMed ID: 16319041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease.
    Storey SG; Suryadevara V; Aronow WS; Ahn C
    J Gerontol A Biol Sci Med Sci; 2003 Dec; 58(12):M1135-6. PubMed ID: 14684711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
    Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
    Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
    Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.
    Ravaglia G; Paola F; Maioli F; Martelli M; Montesi F; Bastagli L; Bianchin M; Chiappelli M; Tumini E; Bolondi L; Licastro F
    Exp Gerontol; 2006 Jan; 41(1):85-92. PubMed ID: 16297587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
    Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
    Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging.
    Mizrahi EH; Jacobsen DW; Debanne SM; Traore F; Lerner AJ; Friedland RP; Petot GJ
    J Nutr Health Aging; 2003; 7(3):160-5. PubMed ID: 12766793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel.
    Mizrahi EH; Bowirrat A; Jacobsen DW; Korczyn AD; Traore F; Petot GJ; Lerner AJ; Debanne SM; Adunsky A; Dibello PM; Friedland RP
    J Neurol Sci; 2004 Dec; 227(1):109-13. PubMed ID: 15546600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
    Nilsson K; Gustafson L; Hultberg B
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):666-72. PubMed ID: 15254923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Homocysteine--marker of vascular disease in elderly with mental illness].
    Hultberg B; Nilsson K; Gustafson L
    Lakartidningen; 2008 Sep 17-23; 105(38):2576-8. PubMed ID: 18846861
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimal use of markers for cobalamin and folate status in a psychogeriatric population.
    Nilsson K; Gustafson L; Hultberg B
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):919-25. PubMed ID: 12325051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia.
    Andersson A; Jonasson T; Ohlin H; Lindgren A; Hultberg B
    Clin Chem Lab Med; 2002 Jun; 40(6):554-8. PubMed ID: 12211647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
    Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Homocysteine related vitamins and lifestyles in the elderly people: The SENECA study].
    Varela-Moreiras G; Escudero JM; Alonso-Aperte E
    Nutr Hosp; 2007; 22(3):363-70. PubMed ID: 17612379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age on plasma homocysteine concentrations in young and elderly subjects considering serum vitamin concentrations and different lifestyle factors.
    Strassburg A; Krems C; Lührmann PM; Hartmann B; Neuhäuser-Berthold M
    Int J Vitam Nutr Res; 2004 Mar; 74(2):129-36. PubMed ID: 15255449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine.
    Annerbo S; Kivipelto M; Lokk J
    Dement Geriatr Cogn Disord; 2009; 28(3):275-80. PubMed ID: 19797897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
    Lu YH; Cheng LM; Huang YH; Lo MY; Wu TJ; Lin HY; Hsu TR; Niu DM
    Clin Nutr; 2015 Dec; 34(6):1155-8. PubMed ID: 25516282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.
    Hooshmand B; Solomon A; Kåreholt I; Leiviskä J; Rusanen M; Ahtiluoto S; Winblad B; Laatikainen T; Soininen H; Kivipelto M
    Neurology; 2010 Oct; 75(16):1408-14. PubMed ID: 20956786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.